Ayuk J - Search Results

1

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly.

Ayuk J, Stewart SE, Stewart PM, Sheppard MC. Ayuk J, et al. J Clin Endocrinol Metab. 2002 Sep;87(9):4142-6. doi: 10.1210/jc.2001-011913. J Clin Endocrinol Metab. 2002. PMID: 12213862 Clinical Trial.

2

Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation.

Rabbitt EH, Ayuk J, Boelaert K, Sheppard MC, Hewison M, Stewart PM, Gittoes NJ. Rabbitt EH, et al. Among authors: ayuk j. Oncogene. 2003 Mar 20;22(11):1663-7. doi: 10.1038/sj.onc.1206293. Oncogene. 2003. PMID: 12642869

3

Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy.

Ayuk J, Stewart SE, Stewart PM, Sheppard MC; European Sandostatin LAR Group. Ayuk J, et al. Clin Endocrinol (Oxf). 2004 Mar;60(3):375-81. doi: 10.1111/j.1365-2265.2004.01992.x. Clin Endocrinol (Oxf). 2004. PMID: 15009004

4

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.

Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. Ayuk J, et al. J Clin Endocrinol Metab. 2004 Apr;89(4):1613-7. doi: 10.1210/jc.2003-031584. J Clin Endocrinol Metab. 2004. PMID: 15070920

5

The role of growth hormone-receptor antagonism in relation to acromegaly.

Ayuk J, Sheppard MC. Ayuk J, et al. Expert Opin Pharmacother. 2004 Nov;5(11):2279-85. doi: 10.1517/14656566.5.11.2279. Expert Opin Pharmacother. 2004. PMID: 15500374 Review.

6

Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking.

Ayuk J, Sheppard MC, Clayton RN, Bates AS, Stewart PM. Ayuk J, et al. J Clin Endocrinol Metab. 2004 Nov;89(11):5867-8; author reply 5868. doi: 10.1210/jc.2004-1475. J Clin Endocrinol Metab. 2004. PMID: 15531556 No abstract available.

7

Acute management of pituitary apoplexy--surgery or conservative management?

Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Ayuk J, et al. Clin Endocrinol (Oxf). 2004 Dec;61(6):747-52. doi: 10.1111/j.1365-2265.2004.02162.x. Clin Endocrinol (Oxf). 2004. PMID: 15579190

8

Letter re: Monitoring the response to treatment in acromegaly.

Ayuk J, Sheppard MC, Bates AS, Stewart PM. Ayuk J, et al. J Clin Endocrinol Metab. 2005 Aug;90(8):4980. doi: 10.1210/jc.2005-0187. J Clin Endocrinol Metab. 2005. PMID: 16087964 No abstract available.

9

Growth hormone and its disorders.

Ayuk J, Sheppard MC. Ayuk J, et al. Postgrad Med J. 2006 Jan;82(963):24-30. doi: 10.1136/pgmj.2005.036087. Postgrad Med J. 2006. PMID: 16397076 Free PMC article. Review.

10

Does acromegaly enhance mortality?

Ayuk J, Sheppard MC. Ayuk J, et al. Rev Endocr Metab Disord. 2008 Mar;9(1):33-9. doi: 10.1007/s11154-007-9067-8. Rev Endocr Metab Disord. 2008. PMID: 18075787 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters